An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation

Monitoring of Trough Plasma Ganciclovir Levels and Peripheral Blood Cytomegalovirus (CMV)-Specific CD8+T Cells To Predict CMV DNAemia Clearance in Preemptively Treated Allogeneic Stem Cell Transplant Recipients

(2014) Estela Giménez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Metabolism of Cyclopropavir and Ganciclovir in Human Cytomegalovirus-Infected Cells

(2014) Brian G. Gentry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy

(2014) C. Stemberger et al.   BLOOD

Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation

(2014) Per Ljungman et al.   CLINICAL INFECTIOUS DISEASES

Letermovir

(2014) P.S. Verghese et al.   DRUGS OF THE FUTURE

Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes

(2014) Isabel Corrales et al.   JOURNAL OF MEDICAL VIROLOGY

Effects of storage time on Cytomegalovirus DNA stability in plasma determined by quantitative real-time PCR

(2014) Li Xie et al.   JOURNAL OF VIROLOGICAL METHODS

Differential Properties of Cytomegalovirus pUL97 Kinase Isoforms Affect Viral Replication and Maribavir Susceptibility

(2014) R. Webel et al.   JOURNAL OF VIROLOGY

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

(2014) Roy F. Chemaly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human Cytomegalovirus Replication Is Strictly Inhibited by siRNAs Targeting UL54, UL97 or UL122/123 Gene Transcripts

(2014) Stuart T. Hamilton et al.   PLoS One

Usefulness of Monitoring Cell-Mediated Immunity for Predicting Post–Kidney Transplantation Viral Infection

(2014) K. Nishikawa et al.   TRANSPLANTATION PROCEEDINGS

Resistance of Human Cytomegalovirus to Cyclopropavir Maps to a Base Pair Deletion in the Open Reading Frame ofUL97

(2013) Brian G. Gentry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

(2013) E. Blyth et al.   BLOOD

Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center

(2013) C Solano et al.   BONE MARROW TRANSPLANTATION

Early Kinetics of Plasma Cytomegalovirus DNA Load in Allogeneic Stem Cell Transplant Recipients in the Era of Highly Sensitive Real-Time PCR Assays: Does It Have Any Clinical Value?

(2013) E. Gimenez et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multicenter Evaluation of a Commercial Cytomegalovirus Quantitative Standard: Effects of Commutability on Interlaboratory Concordance

(2013) R. T. Hayden et al.   JOURNAL OF CLINICAL MICROBIOLOGY

An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting

(2013) Estela Giménez et al.   JOURNAL OF MEDICAL VIROLOGY

Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients

(2013) Dayana Bravo et al.   JOURNAL OF MEDICAL VIROLOGY

The increased sensitivity of human cytomegalovirus (HCMV) PCR quantitation in whole blood affects reproductive rate (Ro) measurement

(2013) Volker Gurtler et al.   JOURNAL OF VIROLOGICAL METHODS

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

(2013) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications

(2013) Siok-Keen Tey et al.   PLoS One

Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature

(2013) N.J. Verkaik et al.   Transplant Infectious Disease

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

(2012) D. J. Winston et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Artemisinin-Derived Dimer Diphenyl Phosphate Is an Irreversible Inhibitor of Human Cytomegalovirus Replication

(2012) Ran He et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation

(2012) Margaret L. Green et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8+T-Cell Response in Allogeneic Stem Cell Transplant Recipients

(2012) María Ángeles Clari et al.   Clinical and Vaccine Immunology

An International Multicenter Performance Analysis of Cytomegalovirus Load Tests

(2012) H. H. Hirsch et al.   CLINICAL INFECTIOUS DISEASES

State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician

(2012) A. Egli et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: The Long Road Toward Standardization of Viral Load Testing for Cytomegalovirus

(2012) A. M. Caliendo   CLINICAL INFECTIOUS DISEASES

Interpreting Quantitative Cytomegalovirus DNA Testing: Understanding the Laboratory Perspective

(2012) C. S. Kraft et al.   CLINICAL INFECTIOUS DISEASES

Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia

(2012) María Ángeles Clari et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo

(2012) Daniele Lilleri et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay

(2012) Milena Furione et al.   JOURNAL OF CLINICAL VIROLOGY

Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

(2012) Corinna La Rosa et al.   JOURNAL OF INFECTIOUS DISEASES

Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin

(2012) A. E. Fouts et al.   JOURNAL OF VIROLOGY

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

(2012) Mohamed A Kharfan-Dabaja et al.   LANCET INFECTIOUS DISEASES

Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

(2012) Daniele Lilleri et al.   PLoS One

Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation

(2012) Sylvia Borchers et al.   PLoS One

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation

(2011) Dana G. Wolf et al.   ANTIVIRAL RESEARCH

Dynamics of Cytomegalovirus (CMV) Plasma DNAemia in Initial and Recurrent Episodes of Active CMV Infection in the Allogeneic Stem Cell Transplantation Setting: Implications for Designing Preemptive Antiviral Therapy Strategies

(2011) Beatriz Muñoz-Cobo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

(2011) B. Foley et al.   BLOOD

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

(2011) N Tormo et al.   BONE MARROW TRANSPLANTATION

Comparative Evaluation of Three Automated Systems for DNA Extraction in Conjunction with Three Commercially Available Real-Time PCR Assays for Quantitation of Plasma Cytomegalovirus DNAemia in Allogeneic Stem Cell Transplant Recipients

(2011) D. Bravo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Factors Contributing to Variability of Quantitative Viral PCR Results in Proficiency Testing Samples: a Multivariate Analysis

(2011) R. T. Hayden et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serum antibody response to the gH/gL/pUL128–131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections

(2011) Emilia Genini et al.   JOURNAL OF CLINICAL VIROLOGY

Cytomegalovirus quantification: Where to next in optimising patient management?

(2011) Claire Atkinson et al.   JOURNAL OF CLINICAL VIROLOGY

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

(2011) Steffanie Sabbaj et al.   JOURNAL OF INFECTIOUS DISEASES

Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK Cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients

(2011) Beatriz Muñoz-Cobo et al.   JOURNAL OF MEDICAL VIROLOGY

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

(2011) T. Goldner et al.   JOURNAL OF VIROLOGY

Polyfunctional T Cells Accumulate in Large Human Cytomegalovirus-Specific T Cell Responses

(2011) R. Lachmann et al.   JOURNAL OF VIROLOGY

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

(2011) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

(2011) S. Lopez-Verges et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation

(2011) Peter A. Andrews et al.   TRANSPLANTATION

Immunological Monitoring for Guidance of Preemptive Antiviral Therapy for Active Cytomegalovirus Infection in Allogeneic Stem-Cell Transplant Recipients: A Pilot Experience

(2011) Carlos Solano et al.   TRANSPLANTATION

“Immuknow” to Measurement of Cell-Mediated Immunity in Renal Transplant Recipients Undergoing Short-Term Evaluation

(2011) P. De Paolis et al.   TRANSPLANTATION PROCEEDINGS

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

(2010) P. Lischka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cytomegalovirus UL97 Mutations Affecting Cyclopropavir and Ganciclovir Susceptibility

(2010) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease

(2010) Nathan Cantoni et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Inhibition of Human Cytomegalovirus Infection by IE86-Specific Short Hairpin RNA-Mediated RNA Interference

(2010) Zhiqiang BAI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study

(2010) J. W. Gratama et al.   BLOOD

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

(2010) T. Feuchtinger et al.   BLOOD

Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT

(2010) L Król et al.   BONE MARROW TRANSPLANTATION

Artesunate is Ineffective in Controlling Valganciclovir-Resistant Cytomegalovirus Infection

(2010) P. Kar Han Lau et al.   CLINICAL INFECTIOUS DISEASES

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

(2010) K. S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections

(2010) L K Dropulic et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

(2010) Albert J. Eid et al.   DRUGS

Antiviral Drug Resistance: Mechanisms and Clinical Implications

(2010) Lynne Strasfeld et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy

(2010) Hubertus C.E. Buyck et al.   JOURNAL OF CLINICAL VIROLOGY

Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays

(2010) Irene Gracia-Ahufinger et al.   JOURNAL OF CLINICAL VIROLOGY

Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: Potential implications for the management of active CMV infection

(2010) Nuria Tormo et al.   JOURNAL OF MEDICAL VIROLOGY

Ex vivo monitoring of human cytomegalovirus-specific CD8+T-Cell responses using the QuantiFERON®-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital

(2010) T. Fleming et al.   JOURNAL OF MEDICAL VIROLOGY

Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab

(2010) Shili Ge et al.   TRANSPLANT IMMUNOLOGY

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

(2010) R.K. Avery et al.   Transplant Infectious Disease

Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8+ T Cells

(2010) George Makedonas et al.   PLoS Pathogens

The ‘Indirect’ Effects of Cytomegalovirus Infection

(2009) R. B. Freeman et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Interlaboratory Comparison of Cytomegalovirus Viral Load Assays

(2009) X. L. Pang et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation

(2009) Hirohisa Nakamae et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

(2009) W. Zhou et al.   BLOOD

How we treat cytomegalovirus in hematopoietic cell transplant recipients

(2009) M. Boeckh et al.   BLOOD

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

(2009) N Tormo et al.   BONE MARROW TRANSPLANTATION

Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)–Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients

(2009) Michelle A. Barron et al.   CLINICAL INFECTIOUS DISEASES

Immunobiology of Human Cytomegalovirus: from Bench to Bedside

(2009) T. Crough et al.   CLINICAL MICROBIOLOGY REVIEWS

Clinical virology of cytomegalovirus infection following hematopoietic transplantation

(2009) Carlos Solano et al.   Future Virology

Efficient inhibition of human cytomegalovirus UL122 gene expression in cell by small interfering RNAs

(2009) Qun-Jun Duan et al.   JOURNAL OF BASIC MICROBIOLOGY

Multi-Site PCR-Based CMV Viral Load Assessment-Assays Demonstrate Linearity and Precision, but Lack Numeric Standardization

(2009) Daynna J. Wolff et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection

(2009) Shahid Husain et al.   TRANSPLANTATION

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers

(2009) David I. Bernstein et al.   VACCINE

Polyfunctional Cytomegalovirus-Specific CD4+ and pp65 CD8+ T Cells Protect Against High-Level Replication After Liver Transplantation

(2008) G. Nebbia et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

(2008) D. J. Winston et al.   BLOOD

Human NK cells can control CMV infection in the absence of T cells

(2008) T. W. Kuijpers et al.   BLOOD

Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation

(2008) L-R Wang et al.   BONE MARROW TRANSPLANTATION

Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT

(2008) B Pourgheysari et al.   BONE MARROW TRANSPLANTATION

CMV infections after hematopoietic stem cell transplantation

(2008) P Ljungman   BONE MARROW TRANSPLANTATION

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

(2008) P Ljungman et al.   BONE MARROW TRANSPLANTATION

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

(2008) G Gerna et al.   BONE MARROW TRANSPLANTATION

Immunocompromised Hosts: Perspectives in the Treatment and Prophylaxis of Cytomegalovirus Disease in Solid‐Organ Transplant Recipients

(2008) Gilberto Torres‐Madriz et al.   CLINICAL INFECTIOUS DISEASES

Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation

(2008) Michael Y. Shapira et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation

(2008) Carol Garcia‐Vidal et al.   CLINICAL INFECTIOUS DISEASES

Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation

(2008) M. Mezger et al.   CLINICAL MICROBIOLOGY AND INFECTION

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection

(2008) D. Lilleri et al.   HAEMATOLOGICA

Enumeration of cytomegalovirus-specific interferon  CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

(2008) C. Solano et al.   HAEMATOLOGICA

Detection of Cytomegalovirus (CMV) DNA in EDTA Whole-Blood Samples: Evaluation of the Quantitative artus CMV LightCycler PCR Kit in Conjunction with Automated Sample Preparation

(2008) B. D. A. Michelin et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients

(2008) C. Gimeno et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Monitoring human cytomegalovirus infection in transplant recipients

(2008) Fausto Baldanti et al.   JOURNAL OF CLINICAL VIROLOGY

Patterns of Cytomegalovirus Reactivation Are Associated with Distinct Evolutive Profiles of Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

(2008) Hélène Moins‐Teisserenc et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

(2008) Mary K. Wloch et al.   JOURNAL OF INFECTIOUS DISEASES

Detection of Cytomegalovirus in Whole Blood Using Three Different Real-Time PCR Chemistries

(2008) Erica Vincent et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Evaluation of an automated extraction system in combination with Affigene® CMV Trender for CMV DNA quantitative determination: Comparison with nested PCR and pp65 antigen test

(2008) I. Abbate et al.   JOURNAL OF VIROLOGICAL METHODS

Reconstitution of Cytomegalovirus Specific T Cells after Pediatric Allogeneic Stem Cell Transplantation: Results from a Pilot Study Using a Multi-Allele CMV Tetramer Group

(2008) U. Koehl et al.   KLINISCHE PADIATRIE

Human CMV vaccine trials: What if CMV caused a rash?

(2007) Stuart P. Adler   JOURNAL OF CLINICAL VIROLOGY

Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment

(2007) Tiziano Allice et al.   JOURNAL OF VIROLOGICAL METHODS